» Articles » PMID: 10477588

Selective Retention of Activated CD8+ T Cells by the Normal Liver

Overview
Journal J Immunol
Date 1999 Sep 8
PMID 10477588
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Activation-induced cell death resulting in peripheral deletion of CD8+ T cells is associated with the accumulation of large numbers of apoptotic T cells in the liver. The hypothesis that this accumulation results from the intrahepatic trapping of T cells from the circulating pool predicts that the liver should retain T cells, which subsequently undergo apoptosis. Here we test this prediction. Perfusion of the liver with lymphocyte mixtures showed retention of activated, but neither resting nor apoptosing, T cells. This trapping was selective for CD8+ cells and was mediated primarily by ICAM-1 constitutively expressed on sinusoidal endothelial cells and Kupffer cells. T cells trapped in the liver became apoptotic. The normal liver is therefore a "sink" for activated T cells.

Citing Articles

Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance.

Kremer K, Khammash H, Miranda A, Rutt L, Twardy S, Anton P Front Immunol. 2025; 15:1497788.

PMID: 39896805 PMC: 11782242. DOI: 10.3389/fimmu.2024.1497788.


Role of T cells in liver metastasis.

Wu K, Zhang G, Shen C, Zhu L, Yu C, Sartorius K Cell Death Dis. 2024; 15(5):341.

PMID: 38755133 PMC: 11099083. DOI: 10.1038/s41419-024-06726-2.


Temporal and spatial dynamics of immune cells in spontaneous liver transplant tolerance.

Que W, Ueta H, Hu X, Morita-Nakagawa M, Fujino M, Ueda D iScience. 2023; 26(9):107691.

PMID: 37694154 PMC: 10485166. DOI: 10.1016/j.isci.2023.107691.


Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers.

Sankar K, Pearson A, Worlikar T, Perricone M, Holcomb E, Mendiratta-Lala M Transl Gastroenterol Hepatol. 2023; 8:29.

PMID: 37601739 PMC: 10432235. DOI: 10.21037/tgh-23-11.


Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives.

Liu Z, Zhu Y, Xie H, Zou Z Front Pharmacol. 2023; 13:1077468.

PMID: 36699050 PMC: 9868416. DOI: 10.3389/fphar.2022.1077468.